Thioredoxin1 as a negative regulator of cardiac hypertrophy

被引:48
作者
Ago, Tetsuro [1 ]
Sadoshima, Junichi [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA
关键词
D O I
10.1089/ars.2007.1529
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Excessive reactive oxygen species (ROS) play an important role in the development of cardiac hypertrophy. In contrast, antioxidants scavenge ROS, thereby maintaining the reduced environment of cells and inhibiting hypertrophy in the heart. Thioredoxin1 (Trx1) not only functions as a major antioxidant in the heart but also interacts with important signaling molecules and transcription factors, thereby attenuating cardiac hypertrophy. This review will discuss the molecular mechanisms by which Trx1 exerts antihypertrophic effects in the heart.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 105 条
[1]   S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells [J].
Adachi, T ;
Pimentel, DR ;
Heibeck, T ;
Hou, XY ;
Lee, YJ ;
Jiang, BB ;
Ido, Y ;
Cohen, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) :29857-29862
[2]   Thioredoxin and ventricular remodeling [J].
Ago, Tetsuro ;
Sadoshima, Junichi .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 41 (05) :762-773
[3]   Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart [J].
Ago, Tetsuro ;
Yeh, Ijen ;
Yamamoto, Mitsutaka ;
Schinke-Braun, Martina ;
Brown, Jeffrey A. ;
Tian, Bin ;
Sadoshima, Junichi .
ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (9-10) :1635-1650
[4]   Cyclic GMP-dependent protein kinase regulates the expression of thioredoxin and thioredoxin peroxidase-1 during hormesis in response to oxidative stress-induced apoptosis [J].
Andoh, T ;
Chiueh, CC ;
Chock, PB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (02) :885-890
[5]   Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer [J].
Arnold, NB ;
Ketterer, K ;
Kleeff, J ;
Friess, H ;
Büchler, MW ;
Korc, M .
CANCER RESEARCH, 2004, 64 (10) :3599-3606
[6]   Fatty acid utilization in the hypertrophied and failing heart: Molecular regulatory mechanisms [J].
Barger, PM ;
Kelly, DP .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (01) :36-42
[7]   PPAR signaling in the control of cardiac energy metabolism [J].
Barger, PM ;
Kelly, DP .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :238-245
[8]   Thioredoxin: friend or foe in human disease? [J].
Burke-Gaffney, A ;
Callister, MEJ ;
Nakamura, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (08) :398-404
[9]   The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].
Butler, LM ;
Zhou, XB ;
Xu, WS ;
Scher, HI ;
Rifkind, RA ;
Marks, PA ;
Richon, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705
[10]   NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease [J].
Cai, H .
CIRCULATION RESEARCH, 2005, 96 (08) :818-822